Home
Dashboard
French Tech Next40/120
French Tech 2030
Curated content
Companies
Job board
Investors
Funding rounds
Exits
Universities
Accelerators
Workspaces
Service providers
More organizations
Investment heatmap
Themes
Investors
Sangel Capital
Portfolio
Portfolio
Save
Sangel Capital
Venture capital
Claimed
Sangel Capital is one of the earliest professional biomedical venture capital institutions in China, focusing on the field of life science.
Overview
Portfolio (0)
Notes
All
Current
Exits
Rounds
Co-Investors
No columns specified